查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
脑脊髓液管理市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品、最终用户和地理位置
市场调查报告书
商品编码
1362402

脑脊髓液管理市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品、最终用户和地理位置

Cerebrospinal Fluid Management Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 177 Pages | 订单完成后即时交付

价格

脑脊髓液管理市场规模预计将从2022年的19,1137万美元增至2030年的2,89,254万美元；预计2022年至2030年复合年增长率为5.3%。

在过去的几十年里，对更好的治疗方式的需求不断增长，导致了各种产品的开发。以下提到了 CSF 管理市场近期产品开发的一些范例。

2022 年 9 月，Anuncia Medical Inc 的 ReFlow System Mini 获得美国食品药物管理局 (FDA) 批准，用于治疗脑积水和其他需要分流的脑脊髓液疾病患者。 ReFlow System Mini 非侵入性地促进脑室导管的冲洗，以恢復、增加或维持分流器中的脑脊髓液流量。

2021 年 3 月，FDA 授予 Anuncia 用于脑脊髓液管理的 ReFlow 系统突破性设备头衔。该设备旨在治疗需要分流的脑脊髓液疾病，例如脑积水。 ReFlow 系统可用于居家照护环境和诊所，以非侵入性方式进行预防性冲洗，以潜在地防止脑脊髓液阻塞。

2020 年 6 月，FDA 授予 Rhaeos, Inc. 提供的 FlowSense 无线非侵入性流量感测器突破性设备称号。该产品旨在快速监测脑积水引起的脑脊髓液过多患者的心室分流功能。

神经系统疾病治疗中对脑脊髓液管理的日益关注为脑脊髓液管理市场提供了新机会

脑脊髓液参数作为成年患者神经系统疾病的生物标记被广泛评估。脑脊髓液中循环的 microRNA 是一类有前景的生物标记物，可用于诊断各种神经系统疾病。帕金森氏症 (PD)、阿兹海默症 (AD)、癫痫和癫痫等神经系统疾病通常会导致脑脊髓液参数改变。根据《自然》杂誌发表的一篇文章，与正常人相比，被诊断为 PD 的患者中发现 76 种脑脊髓液蛋白在结构上发生了变化。该研究还表明，这些脑脊髓液蛋白可用作诊断或治疗该疾病的生物标记。 PD 是一种与认知障碍和马达功能丧失相关的神经退化性疾病。根据世界卫生组织 (WHO) 2022 年发布的报告，帕金森氏症的盛行率在过去 25 年里翻了一番，影响了全球约 1% 的 60 岁以上人口。同样，患有癫痫发作或癫痫持续状态的患者的一些脑脊髓液参数（例如蛋白质和乳酸水平）也会发生变化。因此，利用脑脊髓液参数治疗癫痫发作或癫痫的各种研发活动正在进行中。此外，儘管市场上有各种使用CSF检测阿兹海默症的CSF测定法，但对用于检测和治疗目的的生物标记的需求尚未得到满足。随着阿兹海默症和帕金森氏症病例的增加，对脑脊髓液管理设备的需求也随之增加，因为脑脊髓液漏的病例可能会增加。因此，神经系统疾病盛行率的上升正在推动使用脑脊髓液管理产品治疗这些疾病的研发活动。

脑脊髓液管理市场分为产品和最终用户。根据产品，市场分为脑脊髓液分流器和脑脊髓液引流系统。 2022 年，按产品划分，脑脊髓液分流器细分市场占据最大市场。由于产品推出的增加、对先进脑脊髓液分流器的需求增加以及脑积水发病率的增加，预计同一细分市场在预测期内将以显着的复合年增长率增长。脑脊髓液分流器进一步分为脑室腹膜分流器、脑室心房分流器、脑室胸膜分流器和腰腹膜分流器。基于脑脊髓液分流术，脑室腹腔分流术在脑脊髓液管理市场中占有最大的市场份额，预计在预测期内将以最快的复合年增长率成长。同样，脑脊髓液引流系统分为脑室外引流（EVD）系统和腰椎引流（LD）系统。因此，脑室外引流系统是业界最常用的脑脊髓液引流系统，在该领域占有最大份额。

根据地理位置，市场分为北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。北美在脑脊髓液管理市场中占有最大的市场份额。由于脑积水、创伤性脑损伤和其他神经系统疾病发病率的增加，预计北美市场在预测期内将继续占据主导地位；快速的技术创新；和发展医疗保健基础设施。由于老年人口不断增长、对先进医疗设备的需求以及提供有效治疗的医疗基础设施不断增加等因素，亚太地区成为市场上成长最快的地区。

脑脊髓液管理市场的成长是由一些关键因素决定的，例如脑脊髓液洩漏发生率的增加和脑脊髓液管理产品的不断发展。另一方面，与脑脊髓液分流相关的风险阻碍了市场的成长。

加拿大传染病报告 (CCDR)、疾病管制与预防中心 (CDC)、欧盟、义大利贸易署 (ITA) 是在准备脑脊髓液管理市场报告时提到的几个关键的主要和次要来源。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：脑脊髓液管理市场格局

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 欧洲PEST分析
    • 亚太地区 PEST 分析
    • 南美洲和中美洲 PEST 分析
    • 中东和非洲 PEST 分析

第 5 章：脑脊髓液管理市场 - 主要产业动态

  • 市场驱动因素
    • 脑脊髓液漏率增加
    • CSF 管理产品不断发展
  • 市场限制
    • 与脑脊髓液分流术相关的风险
  • 市场机会
    • 越来越关注使用脑脊髓液管理来治疗神经系统疾病
  • 未来的趋势
    • 脑脊髓液分流术的技术发展
  • 影响分析：

第 6 章：脑脊髓液管理市场 - 全球市场分析

  • 脑脊髓液管理市场收入，2022 - 2030

第 7 章：全球脑脊髓液管理市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 2022 年及 2030 年脑脊髓液管理市场收入份额（按产品划分）
  • 脑脊髓液分流术
  • 脑脊髓液引流系统

第 8 章：全球脑脊髓液管理市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年及 2030 年脑脊髓液管理市场收入份额（按最终用户划分）（%）
  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的

第 9 章：脑脊髓液管理市场 - 地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 阿联酋
    • 沙乌地阿拉伯
    • 南非
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 10 章：Covid-19 前后的影响

  • Covid-19 前后的影响

第 11 章：脑脊髓液管理市场 - 产业格局

  • 概述
  • 2020-2023 年脑脊髓液管理市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • Medtronic Plc
  • Integra LifeSciences Holdings Corp
  • B. Braun SE
  • Argi Group Health Services Ltd Sti
  • Sophysa SA
  • BeckerSmith Medical Inc
  • Delta Surgical Ltd
  • Moller Medical GmbH
  • Natus Medical Inc
  • Spiegelberg GmbH & Co KG

第 13 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPRE00004182

The cerebrospinal fluid management market size is expected to reach US$ 2,892.54 million by 2030 from US$ 1,911.37 million in 2022; it is estimated to record a CAGR of 5.3% from 2022 to 2030.

The growing demand for better treatment modalities has resulted in various product developments in the last few decades. A few of the examples of recent product developments in the CSF management market are mentioned below.

In September 2022, Anuncia Medical Inc received US Food and Drug Administration (FDA) approval for its ReFlow System Mini for the treatment of patients with hydrocephalus and other cerebrospinal fluid disorders that require shunting. ReFlow System Mini noninvasively facilitates a flush of ventricular catheters to restore, increase, or maintain CSF flow in a shunt.

In March 2021, the FDA granted a breakthrough device designation for the ReFlow System of Anuncia for CSF management. The device is designed to treat CSF disorders such as hydrocephalus, which require shunting. ReFlow system can be used in homecare settings and in clinics for prophylactic flushing that is performed noninvasively to potentially prevent CSF blockages.

In June 2020, the FDA granted Breakthrough Device Designation to the FlowSense wireless, noninvasive flow sensor offered by Rhaeos, Inc. The product is designed to rapidly monitor ventricular shunt function in patients with excess cerebrospinal fluid caused by hydrocephalus.

Increasing Focus on CSF Management in Neurological Disease Treatments Provides New Opportunities for the Cerebrospinal Fluid Management Market

CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson's Disease (PD), Alzheimer's Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer's disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer's disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.

The cerebrospinal fluid management market is segments into product and end user. Based on product, the market is bifurcated into CSF shunts and CSF drainage systems. In 2022, the CSF shunts segment held the largest share of the market by product. and the same segment is estimated to grow at a significant CAGR during the forecast period due to growing product launches, increasing demand for advanced CSF shunts, and increasing incidences of hydrocephalus. CSF shunts was further segmented into ventriculoperitoneal shunts, ventriculoatrial shunts, ventriculopleural shunts, and lumboperitoneal shunts. Based on CSF shunts, ventriculoperitoneal shunts held the largest market share of cerebrospinal fluid management market and is expected to grow at a fastest CAGR during the forecast period. Similarly, the CSF drainage systems were classified into external ventricular drainage (EVD) systems and lumbar drainage (LD) systems. External ventricular drainage systems are the more commonly used CSF drainage systems in the industry therefore, marking largest share of the segment.

Based on geography, the market is segmented into North America, Europe, Asia Pacific Middle East & Africa, and South & Central America. North America held the largest market share of the cerebrospinal fluid management market. The market in North America is expected to continue its dominance during the forecast period due to the increasing hydrocephalus, traumatic brain injury, and other neurological condition incidences; rapid technological innovations; and developing healthcare infrastructure. Whereas Asia Pacific is the fastest growing region in the market owing to the factors, including growing geriatric population, demand for advanced medical devices, and increasing healthcare infrastructures offering efficient treatments.

The growth of cerebrospinal fluid management market is defined by some of the key factors, such as increasing incidences of CSF leak and growing developments for CSF management products. On the other hand, the risk associated with CSF shunts hinders the market growth.

The Canada Communicable Disease Report (CCDR), Centers for Disease Control and Prevention (CDC), European Union, Italian Trade Agency (ITA) are a few key primary and secondary sources referred to while preparing the report on the cerebrospinal fluid management market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the cerebrospinal fluid management.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global cerebrospinal fluid management, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global cerebrospinal fluid management trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Cerebrospinal Fluid Management Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis

5. Cerebrospinal Fluid Management Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of CSF Leak
    • 5.1.2 Growing Developments for CSF Management Products
  • 5.2 Market Restraints
    • 5.2.1 Risk Associated with CSF Shunts
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Focus on Use of CSF Management for Treatment of Neurological Diseases
  • 5.4 Future Trends
    • 5.4.1 Technological Developments for CSF Shunts
  • 5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - Global Market Analysis

  • 6.1 Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. Global Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 CSF Shunts
    • 7.3.1 Overview
    • 7.3.2 CSF Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Ventriculoperitoneal Shunts
      • 7.3.3.1 Overview
      • 7.3.3.2 Ventriculoperitoneal Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Ventriculoatrial Shunts
      • 7.3.4.1 Overview
      • 7.3.4.2 Ventriculoatrial Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Ventriculopleural Shunts
      • 7.3.5.1 Overview
      • 7.3.5.2 Ventriculopleural Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Lumboperitoneal Shunts
      • 7.3.6.1 Overview
      • 7.3.6.2 Lumboperitoneal Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 CSF Drainage Systems
    • 7.4.1 Overview
    • 7.4.2 CSF Drainage Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 External Ventricular Drainage (EVD) Systems
      • 7.4.3.1 Overview
      • 7.4.3.2 External Ventricular Drainage (EVD) Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Lumbar Drainage (LD) Systems
      • 7.4.4.1 Overview
      • 7.4.4.2 Lumbar Drainage (LD) Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinics
    • 8.4.1 Overview
    • 8.4.2 Clinics: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Ambulatory Surgical Centers
    • 8.5.1 Overview
    • 8.5.2 Ambulatory Surgical Centers: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. Cerebrospinal Fluid Management Market - Geographical Analysis

  • 9.1 North America Cerebrospinal Fluid Management Market, Revenue and Forecast To 2030
    • 9.1.1 Overview
    • 9.1.2 North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.1.2.1 North America Cerebrospinal Fluid Management Market, by Product
        • 9.1.2.1.1 North America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.2.1.2 North America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.1.2.2 North America Cerebrospinal Fluid Management Market, by End User
      • 9.1.2.3 North America Cerebrospinal Fluid Management Market, by Country
      • 9.1.2.4 US
        • 9.1.2.4.1 Overview
        • 9.1.2.4.2 US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.2.4.3 US Cerebrospinal Fluid Management Market, by Product
        • 9.1.2.4.3.1 US Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.2.4.3.2 US Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.2.4.4 US Cerebrospinal Fluid Management Market, by End User
      • 9.1.2.5 Canada
        • 9.1.2.5.1 Overview
        • 9.1.2.5.2 Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.2.5.3 Canada Cerebrospinal Fluid Management Market, by Product
        • 9.1.2.5.3.1 Canada Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.2.5.3.2 Canada Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.2.5.4 Canada Cerebrospinal Fluid Management Market, by End User
      • 9.1.2.6 Mexico
        • 9.1.2.6.1 Overview
        • 9.1.2.6.2 Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.2.6.3 Mexico Cerebrospinal Fluid Management Market, by Product
        • 9.1.2.6.3.1 Mexico Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.2.6.3.2 Mexico Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.2.6.4 Mexico Cerebrospinal Fluid Management Market, by End User
  • 9.2 Europe Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
    • 9.2.1 Overview
    • 9.2.2 Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.2.2.1 Europe Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.1.1 Europe Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.1.2 Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.2.2.2 Europe Cerebrospinal Fluid Management Market, by End User
      • 9.2.2.3 Europe Cerebrospinal Fluid Management Market, by Country
      • 9.2.2.4 UK
        • 9.2.2.4.1 Overview
        • 9.2.2.4.2 UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.2.4.3 UK Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.4.3.1 UK Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.4.3.2 UK Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.2.2.4.4 UK Cerebrospinal Fluid Management Market, by End User
      • 9.2.2.5 Germany
        • 9.2.2.5.1 Overview
        • 9.2.2.5.2 Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.2.5.3 Germany Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.5.3.1 Germany Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.5.3.2 Germany Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.2.2.5.4 Germany Cerebrospinal Fluid Management Market, by End User
      • 9.2.2.6 France
        • 9.2.2.6.1 Overview
        • 9.2.2.6.2 France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.2.6.3 France Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.6.3.1 France Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.6.3.2 France Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.2.2.6.4 France Cerebrospinal Fluid Management Market, by End User
      • 9.2.2.7 Italy
        • 9.2.2.7.1 Overview
        • 9.2.2.7.2 Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.2.7.3 Italy Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.7.3.1 Italy Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.7.3.2 Italy Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.2.2.7.4 Italy Cerebrospinal Fluid Management Market, by End User
      • 9.2.2.8 Spain
        • 9.2.2.8.1 Overview
        • 9.2.2.8.2 Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.2.8.3 Spain Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.8.3.1 Spain Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.8.3.2 Spain Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.2.2.8.4 Spain Cerebrospinal Fluid Management Market, by End User
      • 9.2.2.9 Rest of Europe
        • 9.2.2.9.1 Overview
        • 9.2.2.9.2 Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.2.9.3 Rest of Europe Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.9.3.1 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.9.3.2 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.2.2.9.4 Rest of Europe Cerebrospinal Fluid Management Market, by End User
  • 9.3 Asia Pacific Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.2.1 Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.1.1 Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.1.2 Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.3.2.2 Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.3.2.3 Asia Pacific Cerebrospinal Fluid Management Market, by Country
      • 9.3.2.4 China
        • 9.3.2.4.1 Overview
        • 9.3.2.4.2 China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.2.4.3 China Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.4.3.1 China Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.4.3.2 China Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.3.2.4.4 China Cerebrospinal Fluid Management Market, by End User
      • 9.3.2.5 Japan
        • 9.3.2.5.1 Overview
        • 9.3.2.5.2 Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.2.5.3 Japan Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.5.3.1 Japan Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.5.3.2 Japan Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.3.2.5.4 Japan Cerebrospinal Fluid Management Market, by End User
      • 9.3.2.6 India
        • 9.3.2.6.1 Overview
        • 9.3.2.6.2 India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.2.6.3 India Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.6.3.1 India Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.6.3.2 India Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.3.2.6.4 India Cerebrospinal Fluid Management Market, by End User
      • 9.3.2.7 Australia
        • 9.3.2.7.1 Overview
        • 9.3.2.7.2 Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.2.7.3 Australia Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.7.3.1 Australia Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.7.3.2 Australia Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.3.2.7.4 Australia Cerebrospinal Fluid Management Market, by End User
      • 9.3.2.8 South Korea
        • 9.3.2.8.1 Overview
        • 9.3.2.8.2 South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.2.8.3 South Korea Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.8.3.1 South Korea Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.8.3.2 South Korea Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.3.2.8.4 South Korea Cerebrospinal Fluid Management Market, by End User
      • 9.3.2.9 Rest of Asia Pacific
        • 9.3.2.9.1 Overview
        • 9.3.2.9.2 Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.2.9.3 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.9.3.1 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.9.3.2 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.3.2.9.4 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by End User
  • 9.4 Middle East & Africa Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.4.2.1 Middle East & Africa Cerebrospinal Fluid Management Market, by Product
        • 9.4.2.1.1 Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.4.2.1.2 Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.4.2.2 Middle East & Africa Cerebrospinal Fluid Management Market, by End User
      • 9.4.2.3 Middle East & Africa Cerebrospinal Fluid Management Market, by Country
      • 9.4.2.4 UAE
        • 9.4.2.4.1 Overview
        • 9.4.2.4.2 UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.2.4.3 UAE Cerebrospinal Fluid Management Market, by Product
        • 9.4.2.4.3.1 UAE Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.4.2.4.3.2 UAE Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.4.2.4.4 UAE Cerebrospinal Fluid Management Market, by End User
      • 9.4.2.5 Saudi Arabia
        • 9.4.2.5.1 Overview
        • 9.4.2.5.2 Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.2.5.3 Saudi Arabia Cerebrospinal Fluid Management Market, by Product
        • 9.4.2.5.3.1 Saudi Arabia Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.4.2.5.3.2 Saudi Arabia Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.4.2.5.4 Saudi Arabia Cerebrospinal Fluid Management Market, by End User
      • 9.4.2.6 South Africa
        • 9.4.2.6.1 Overview
        • 9.4.2.6.2 South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.2.6.3 South Africa Cerebrospinal Fluid Management Market, by Product
        • 9.4.2.6.3.1 South Africa Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.4.2.6.3.2 South Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.4.2.6.4 South Africa Cerebrospinal Fluid Management Market, by End User
      • 9.4.2.7 Rest of Middle East & Africa
        • 9.4.2.7.1 Overview
        • 9.4.2.7.2 Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.2.7.3 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by Product
        • 9.4.2.7.3.1 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.4.2.7.3.2 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.4.2.7.4 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by End User
  • 9.5 South & Central America Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
    • 9.5.1 Overview
    • 9.5.2 South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.5.2.1 South & Central America Cerebrospinal Fluid Management Market, by Product
        • 9.5.2.1.1 South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.5.2.1.2 South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.5.2.2 South & Central America Cerebrospinal Fluid Management Market, by End User
      • 9.5.2.3 South & Central America Cerebrospinal Fluid Management Market, by Country
      • 9.5.2.4 Brazil
        • 9.5.2.4.1 Overview
        • 9.5.2.4.2 Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.2.4.3 Brazil Cerebrospinal Fluid Management Market, by Product
        • 9.5.2.4.3.1 Brazil Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.5.2.4.3.2 Brazil Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.5.2.4.4 Brazil Cerebrospinal Fluid Management Market, by End User
      • 9.5.2.5 Argentina
        • 9.5.2.5.1 Overview
        • 9.5.2.5.2 Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.2.5.3 Argentina Cerebrospinal Fluid Management Market, by Product
        • 9.5.2.5.3.1 Argentina Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.5.2.5.3.2 Argentina Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.5.2.5.4 Argentina Cerebrospinal Fluid Management Market, by End User
      • 9.5.2.6 Rest of South & Central America
        • 9.5.2.6.1 Overview
        • 9.5.2.6.2 Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.2.6.3 Rest of South & Central America Cerebrospinal Fluid Management Market, by Product
        • 9.5.2.6.3.1 Rest of South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.5.2.6.3.2 Rest of South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.5.2.6.4 Rest of South & Central America Cerebrospinal Fluid Management Market, by End User

10. Pre & Post Covid-19 Impact

  • 10.1 Pre & Post Covid-19 Impact

11. Cerebrospinal Fluid Management Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in The Cerebrospinal Fluid Management Market, 2020-2023
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Medtronic Plc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Integra LifeSciences Holdings Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 B. Braun SE
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Argi Group Health Services Ltd Sti
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Sophysa SA
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 BeckerSmith Medical Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Delta Surgical Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Moller Medical GmbH
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Natus Medical Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Spiegelberg GmbH & Co KG
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Cerebrospinal Fluid Management Market Segmentation
  • Table 2. North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 3. North America Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Shunts
  • Table 4. North America Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Drainage Systems
  • Table 5. North America Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - End User
  • Table 6. US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 7. US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 8. US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 9. US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 10. Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 11. Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 12. Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 13. Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 14. Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 15. Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 16. Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 17. Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 18. Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 19. Europe Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Shunts
  • Table 20. Europe Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Drainage Systems
  • Table 21. Europe Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - End User
  • Table 22. UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 23. UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 24. UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 25. UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 26. Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 27. Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 28. Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 29. Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 30. France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 31. France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 32. France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 33. France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 34. Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 35. Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 36. Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 37. Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 38. Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 39. Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 40. Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 41. Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 42. Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 43. Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 44. Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 45. Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 46. Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 47. Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Shunts
  • Table 48. Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Drainage Systems
  • Table 49. Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - End User
  • Table 50. China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 51. China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 52. China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 53. China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 54. Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 55. Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 56. Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 57. Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 58. India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 59. India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 60. India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 61. India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 62. Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 63. Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 64. Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 65. Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 66. South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 67. South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 68. South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 69. South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 70. Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 71. Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 72. Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 73. Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 74. Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 75. Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Shunts
  • Table 76. Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Drainage Systems
  • Table 77. Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - End User
  • Table 78. UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 79. UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 80. UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 81. UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 82. Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 83. Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 84. Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 85. Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 86. South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 87. South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 88. South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 89. South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 90. Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 91. Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 92. Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 93. Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 94. South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 95. South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Shunts
  • Table 96. South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Drainage Systems
  • Table 97. South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - End User
  • Table 98. Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 99. Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 100. Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 101. Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 102. Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 103. Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 104. Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 105. Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 106. Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 107. Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 108. Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 109. Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 110. Recent Inorganic Growth Strategies in the Cerebrospinal Fluid Management Market
  • Table 111. Recent Organic Growth Strategies in The Cerebrospinal Fluid Management Market
  • Table 112. Glossary of Terms, Cerebrospinal Fluid Management Market

List Of Figures

  • Figure 1. Cerebrospinal Fluid Management Market Segmentation, By Geography
  • Figure 2. North America - PEST Analysis
  • Figure 3. Europe - PEST Analysis
  • Figure 4. Asia Pacific - PEST Analysis
  • Figure 5. South & Central America - PEST Analysis
  • Figure 6. Middle East & Africa - PEST Analysis
  • Figure 7. Cerebrospinal Fluid Management Market - Key Industry Dynamics
  • Figure 8. Impact Analysis of Drivers and Restraints
  • Figure 9. Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030
  • Figure 10. Cerebrospinal Fluid Management Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 11. Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 12. CSF Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Ventriculoperitoneal Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Ventriculoatrial Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Ventriculopleural Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Lumboperitoneal Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. CSF Drainage Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. External Ventricular Drainage (EVD) Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Lumbar Drainage (LD) Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 21. Hospitals: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Clinics: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Ambulatory Surgical Centers: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Cerebrospinal Fluid Management Market, 2022 ($Mn)
  • Figure 26. North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. North America Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 28. US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Europe Cerebrospinal Fluid Management Market, By Geography, 2022 ($Mn)
  • Figure 32. Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Europe Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 34. UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. Cerebrospinal Fluid Management Market, By Geography, 2022 ($Mn)
  • Figure 41. Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Asia Pacific Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 43. China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 44. Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Cerebrospinal Fluid Management Market, By Geography, 2022 and 2030 ($Mn)
  • Figure 50. Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 51. Middle East & Africa Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 52. UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 53. Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. Cerebrospinal Fluid Management Market, By Geography, 2022 ($Mn)
  • Figure 57. South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. South & Central America Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 59. Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 60. Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 62. Pre & Post Covid-19 Impact
  • Figure 63. Growth Strategies in The Cerebrospinal Fluid Management Market, 2020-2023